Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Wnt/β-catenin

Items 1-10 of 40

Page
per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     28 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor
      ≥23.27 mg/mL
  2. FH535
    A3413 FH535
    Summary: Wnt/B-catenin inhibitor
      ≥36.1 mg/mL
  3. IWP-2
    A3512 IWP-2
     2 Citation
    Summary: Wnt production inhibitor,PORCN inhibitor
      ≥23.35 mg/mL
  4. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  5. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  6. KY 02111
    A8213 KY 02111
    Summary: WNT signaling inhibitor
      insoluble in H2O; ≥18.85 mg/mL
  7. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  8. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  9. Tankyrase Inhibitors (TNKS) 22
    A8600 Tankyrase Inhibitors (TNKS) 22
    Summary: Tankyrase inhibitor
  10. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: Tankyrase inhibitor
      ≥22.45 mg/mL

Items 1-10 of 40

Page
per page